Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2023-05-04 00:00:00 ET · period of report 2023-05-02 · accession 0001209191-23-027374 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-05-04 | 2023-05-02+ | VRTX | Sanna Bastiano | EVP, Cell, Genetic Therapies | S - Sale | $350.71 | -4,403 | 35.3K | -11% | -$1.54M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-02 | S | D | 1,411 | $350.32 | 38,302 | D | — | — | (F2) Mr. Sanna undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F3) Open market sales reported on this line occurred at a weighted average price of $350.32 (range $350.00 to $350.92). |
| 2 | Common | Common Stock | 2023-05-02 | S | D | 42 | $351.65 | 38,260 | D | — | — | (F2) Mr. Sanna undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F4) Open market sales reported on this line occurred at a weighted average price of $351.65 (range $351.48 to $351.80). |
| 3 | Common | Common Stock | 2023-05-02 | S | D | 169 | $353.24 | 38,091 | D | — | — | (F2) Mr. Sanna undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F5) Open market sales reported on this line occurred at a weighted average price of $353.24 (range $353.21 to $353.49). |
| 4 | Common | Common Stock | 2023-05-03 | S | D | 2,053 | $350.44 | 36,038 | D | — | — | (F6) Open market sales reported on this line occurred at a weighted average price of $350.44 (range $350.00 to $350.94). (F2) Mr. Sanna undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 5 | Common | Common Stock | 2023-05-03 | S | D | 728 | $351.60 | 35,310 | D | — | — | (F2) Mr. Sanna undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F7) Open market sales reported on this line occurred at a weighted average price of $351.60 (range $351.01 to $352.00). |